article thumbnail

New for 2022, California Estheticians Can Perform Brow Lamination, Lash Lifts & Tints!

California Skincare Supply

July, 2022 News Update FDA has approved lash and brow tinting for estheticians, and Refectocil has stepped up to the plate with their new product to meet the need. Read the actual bill hereā€¦ But the FDA steps in with a warning in January 2022 That all sounds great, but there’s one problem. Estheticians can! That’s right.

article thumbnail

Review Study Aims to Refine Safety Profile of JAK Inhibitors in AD

The Dermatology Digest

The comprehensive safety analysis establishes evidence regarding the safety of systematic Janus kinase inhibitors in patients with atopic dermatitis. They reviewed the available safety data and analyzed the risk of 11 adverse events from 14 RCTs published between 2019 and 2022.

Safety 36
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Review Study Aims to Refine Safety Profile of JAK Inhibitors in AD

The Dermatology Digest

They reviewed the available safety data and analyzed the risk of 11 adverse events from 14 RCTs published between 2019 and 2022. The post Review Study Aims to Refine Safety Profile of JAK Inhibitors in AD appeared first on The Dermatology Digest.

Safety 36
article thumbnail

And Then There Were Sixā€¦FDA Green Lights Hugelā€™s Toxin for Glabellar Lines

The Dermatology Digest

.” Coral Gables, FL-based dermatologist Joely Kaufman, MD, adds, “The results from the clinical trials for letibotulinumtoxinA demonstrate efficacy, and a convincing safety profile in the treatment of glabellar lines. Hugel filed its first Biologics License Application in 2021, which was rejected by the FDA in 2022.

article thumbnail

Using CO2 Laser + Other Modalities to Treat Skin Pigmentation

Lipgloss and Aftershave

Sequence Treatments for Safety: Estheticians can schedule less invasive treatments first and reserve higher-intensity therapies for later sessions to reduce skin sensitization. Medium Depth Peels: Peels with trichloroacetic acid (TCA) penetrate deeper, providing a more significant exfoliation. Aesthetic Surgery Journal. Dermatology Research.

article thumbnail

Increasing Rate of Medical Mistakes and Misdiagnosis

Aesthetics Advisor

But about 11% of the time, 4 medical conditions are misdiagnosed, according to research published in BMJ Quality & Safety. In 2016, Johns Hopkins patient safety experts, led by Dr. Martin Makary, calculated that more than 250,000 patients died each year from medical errors, making it the third leading cause of death.

Medical 36
article thumbnail

Biosimilar News: Stada, Alvotech Launch the First Ustekinumab Biosimilar Across Europe

The Dermatology Digest

In January 2024, Uzpruvo became the first ustekinumab biosimilar to be approved by the European Commission as having equivalent efficacy, safety, pharmacokinetics and immunogenicity to the Stelara reference product. Uzpruvo was developed, and is manufactured and packaged, entirely within Europe, and has a 36-month shelf life.